Eli Lilly & Co. Faces Challenges as Backorders and Delays Impact Availability of New Weight Loss Drug Zepbound
Limited Availability of Eli Lilly’s New Weight Loss Drug Supply Issues Impact Availability Eli Lilly & Co. revealed that patients across the United States are facing obstacles in obtaining their prescription of the newly launched weight loss drug, Zepbound. Frustration heightens as backorders and delays involving the medication continue to surge, denying patients timely access. … Read more